📰 Psychedelics News

Curated updates on microdosing, research, policy, and community.

Filters

2026-02-27 The Microdose (Berkeley)

The FDA is changing the drug approval process; In a Senate hearing, Surgeon General nominee Casey Means was asked about psychedelics use

Plus: RAND survey shows that nearly a quarter of U.S. adults support legal use of psilocybin mushrooms; Reunion Neuroscience gets FDA Breakthrough Therapy status for shorter acting psychedelic

2026-02-27 Psychedelic Alpha

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

In this conversation with Psychedelic Alpha’s Josh Hardman, Dr. Terence Ching discusses his journey into the field and current work leading Yale’s psilocybin trials for OCD. He reflects on study design considerations,...

2026-02-27 Tripsitter (Substack)

Can Psychedelics Break the Consumption Cycle?

Consumer culture doesn’t just shape what we buy — it shapes what we want. Here’s why that’s harder to escape than you think.

2026-02-27 The Psychedelic Blog (Substack)

Psychedelics Can Just Be for Fun

Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.

2026-02-27 DoubleBlind Magazine

Meet the Collector Putting Psychedelic Art on the Map

Inside the obsessive hunt that turned Brian Chambers into a force in psychedelic counterculture. [...] Read More... The post Meet the Collector Putting Psychedelic Art on the Map appeared first on DoubleBlind Mag.

2026-02-27 OPEN Foundation

Ketamine-Assisted Psychotherapy for Mental Disorders: What Does the Evidence Actually Show?

A new systematic review in Clinical Psychology Review offers the most comprehensive overview to date of studies combining ketamine with psychotherapy across psychiatric indications. The findings are promising, but the...

2026-02-26 ICEERS

Honoring Peace Award for Natalia Rebollo in Mexico

On February 19, the Mexican Chamber of Deputies hosted the “Honoring Peace” ceremony, an event dedicated to recognizing individuals whose careers have made a significant contribution to justice, the common good, and t...

2026-02-26 ICEERS

Uso de ayahuasca ou Cannabis mantém neurocognição normal

The post Uso de ayahuasca ou Cannabis mantém neurocognição normal appeared first on ICEERS.

2026-02-26 Breaking Convention (Substack)

Things to do, places to go 🤩

Our Trip Sitting course starts today

2026-02-26 Chemical Collective

Psychedelics and Somatic Flashbacks

Somatic flashbacks involve the re-experiencing of intense bodily sensations from a traumatic event. While psychedelics and emerging therapies aim to unlock and heal these responses, they also carry the risk of retraum...

2026-02-25 ICEERS

Personality in Ayahuasca and Cannabis Users

Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users Authors:José Carlos Bouso, Oscar Andión, Sabela Fondevila Estévez, Débora González, Miguel Ángel Alcázar-Córcoles, Maja Koh...

Research
2026-02-25 DoubleBlind Magazine

Ancient Clues to Psychoactive Plants in Scripture

From mandrake to manna, a closer look at Scripture’s sacred plants. [...] Read More... The post Ancient Clues to Psychoactive Plants in Scripture appeared first on DoubleBlind Mag.

2026-02-25 Microdose (industry)

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

In a development that could ripple across the fast evolving neuroplastogen sector, Enveric Biosciences announced that a Post Grant Review petition filed against one of its key U.S. patents has been withdrawn. The deci...

2026-02-25 Lucid News

New RAND Report Shows Therapeutic Use Driving U.S. Views Towards Psychedelics

A new report from the RAND Corporation shows that nearly one-quarter of U.S. adults now support the legal use of psilocybin with public support driven by approval for therapeutic not personal access or recreational us...

Policy
2026-02-24 Psychedelics Today

Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life

Scott Shannon, MD What if classic psychedelic medicines like psilocybin don’t heal primarily by changing brain chemistry, but by changing how reality itself is perceived? In clinical psychedelic work and research, we’...